Dynein cell light intermediate chain 1 (DYNC1LI1) influences the sensitivity of colorectal cancer to radiation and chemotherapy and is linked to pancreatic ductal adenocarcinoma, hepatocellular carcinoma and prostate cancer.33 Here, DYNC1LI1 is linked to prostate cancer.